Conmed (CNMD) Gross Profit (2016 - 2026)
Conmed filings provide 17 years of Gross Profit readings, the most recent being $183.4 million for Q1 2026.
- On a quarterly basis, Gross Profit rose 3.2% to $183.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $756.2 million, a 2.35% increase, with the full-year FY2025 number at $750.5 million, up 2.38% from a year prior.
- Gross Profit hit $183.4 million in Q1 2026 for Conmed, down from $218.3 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $218.3 million in Q4 2025 to a low of $131.9 million in Q4 2022.
- Median Gross Profit over the past 5 years was $172.0 million (2024), compared with a mean of $171.4 million.
- Biggest five-year swings in Gross Profit: decreased 15.39% in 2022 and later skyrocketed 38.16% in 2023.
- Conmed's Gross Profit stood at $131.9 million in 2022, then skyrocketed by 38.16% to $182.2 million in 2023, then rose by 8.88% to $198.3 million in 2024, then grew by 10.05% to $218.3 million in 2025, then dropped by 15.96% to $183.4 million in 2026.
- The last three reported values for Gross Profit were $183.4 million (Q1 2026), $218.3 million (Q4 2025), and $166.1 million (Q3 2025) per Business Quant data.